VisserWEVrijmoethPVisserFEArtsWFvan ToorHVisserTJ. Identification, functional analysis, prevalence and treatment of monocarboxylate transporter 8 (MCT8) mutations in a cohort of adult patients with mental retardation. Clin Endocrinol (Oxf). 2013;78:310-315.
2.
López-EspíndolaDMorales-BastosCGrijota-MartínezC. Mutations of the thyroid hormone transporter MCT8 cause prenatal brain damage and persistent hypomyelination. J Clin Endocrinol Metab. 2014;99:E2799-E2804.
3.
LeyenaarJCamfieldPCamfieldC. A schematic approach to hypotonia in infancy. Paediatr Child Health. 2005;10:397-400.
4.
FuJDumitrescuAM. Inherited defects in thyroid hormone cell-membrane transport and metabolism. Best Pract Res Clin Endocrinol Metab. 2014;28:189-201.
5.
FuJRefetoffSDumitrescuAM. Inherited defects of thyroid hormone-cell-membrane transport: review of recent findings. Curr Opin Endocrinol Diabetes Obes. 2013;20:434-440.
6.
ZungAVisserTJUitterlindenAGRivadeneiraFFriesemaEC. A child with a deletion in the monocarboxylate transporter 8 gene: 7-year follow-up and effects of thyroid hormone treatment. Eur J Endocrinol. 2011;165:823-830.
VergeCFKonradDCohenM. Diiodothyropropionic acid (DITPA) in the treatment of MCT8 deficiency. J Clin Endocrinol Metab. 2012;97:4515-4523.
9.
FerraraAMLiaoXHGil-IbáñezP. Changes in thyroid status during perinatal development of MCT8-deficient male mice. Endocrinology. 2013;154:2533-2541.
10.
ZhangYConradAHConradGW. Detection and quantification of 3,5,3′-triiodothyronine and 3,3′,5′-triiodothyronine by electrospray ionization tandem mass spectrometry. J Am Soc Mass Spectrom. 2005;16:1781-1786.
11.
RodriguesFGrenhaJOrtezC. Hypotonic male infant and MCT8 deficiency—a diagnosis to think about. BMC Pediatr. 2014;14:252.
